Retina Associates of Utah

Clinical research site in Salt Lake City, Utah · 5169 COTTONWOOD ST STE 630, SALT LAKE CITY, UT 84107-6771 · (801) 281-3030 · Website

As of September 2026, 6 paid clinical trials are recruiting at Retina Associates of Utah in Salt Lake City, Utah. Active studies at this site cover conditions such as Neovascular Age-related Macular Degeneration, nAMD and Macular Degeneration. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

New trial at Retina Associates of Utah? We'll email you when one opens.

Recruiting clinical trials at Retina Associates of Utah (6)

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for Neovascular Age-related Macular Degeneration

53 locations incl. Fullerton

Sponsor: Amgen

Sex: All·Age: 50+

Code: NCT07614776·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for Macular Degeneration

61 locations incl. Scottsdale

Sponsor: EyeBiotech Ltd.

Sex: All·Age: 50+

Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

52 locations incl. Bakersfield

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449936·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration

78 locations incl. Gilbert

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All·Age: 60+

Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for Age-related Macular Degeneration (AMD)

141 locations incl. Chandler

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 50 - 85

Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for Neovascular Age-related Macular Degeneration

33 locations incl. Mesa

Sponsor: Genentech, Inc.

Sex: All·Age: 50+

Code: NCT04853251·Phase 4·Recruiting·Listed Apr 2021

Apply to this trial

Get new-trial alerts for Retina Associates of Utah

We'll email you whenever a new clinical trial starts recruiting at this research site in Salt Lake City, UT. Unsubscribe anytime.

More research sites in Salt Lake City

University of Utah (211 trials)
Huntsman Cancer Institute/University of Utah (73 trials)
Primary Children's Hospital (60 trials)
Huntsman Cancer Institute (59 trials)
Huntsman Cancer Institute, University of Utah (34 trials)
University of Utah Health (28 trials)
Huntsman Cancer Institute at University of Utah (22 trials)
University of Utah Hospital (21 trials)
VA Salt Lake City Health Care System, Salt Lake City, UT (17 trials)
University of Utah Sugarhouse Health Center (16 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Salt Lake City, UT · Utah clinical trials